Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Milan Radovich

Showing results (21-30 of 102) with videos related to

Pageof 11
Sort By:
Frontiers in Oncology|November 4, 2022
A phase II study of buparlisib in relapsed or refractory thymomasMohammad I Abu Zaid, Milan Radovich, Sandra Althouse, et al.
NPJ Breast Cancer|June 27, 2017
Dual PI3K and Wnt pathway inhibition is a synergistic combination against triple negative breast cancerJeffrey P Solzak, Rutuja V Atale, Bradley A Hancock, et al.
JCO Precision Oncology|February 14, 2023
Clinicogenomic Landscape of Metastatic Thymic Epithelial TumorsFatemeh Ardeshir-Larijani, Bryan P Schneider, Sandra K Althouse, et al.
Cancer Cell|October 17, 2025
TET2-mutant clonal hematopoiesis enhances macrophage antigen presentation and improves immune checkpoint therapy in solid tumorsShelley Herbrich, Mehdi Chaib, Swetha Anandhan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2018
Germline and Somatic DNA Damage Repair Gene Mutations and Overall Survival in Metastatic Pancreatic Adenocarcinoma Patients Treated with FOLFIRINOXAmikar Sehdev, Olumide Gbolahan, Brad A Hancock, et al.
JCO Precision Oncology|January 20, 2022
Implications of Incidental Germline Findings Identified In the Context of Clinical Whole Exome Sequencing for Guiding Cancer TherapyBryan P Schneider, Leigh Anne Stout, Santosh Philips, et al.
Plos Biology|September 30, 2017
Transcriptome analysis of hypoxic cancer cells uncovers intron retention in EIF2B5 as a mechanism to inhibit translationLauren K Brady, Hejia Wang, Caleb M Radens, et al.
JCO Precision Oncology|February 9, 2022
Homologous Recombination Deficiency in Patients With Pancreatic Ductal Adenocarcinoma and Response to ChemotherapySafi Shahda, Kirsten M Timms, Ashley A Ibrahim, et al.
Journal of Leukocyte Biology|February 8, 2006
DC-SIGN (CD209) recognition of Neisseria gonorrhoeae is circumvented by lipooligosaccharide variationPei Zhang, Olivier Schwartz, Milica Pantelic, et al.
Breast Cancer Research : BCR|August 12, 2025
Comparison of trastuzumab deruxtecan and sacituzumab govitecan in HER2-negative metastatic breast cancer: a large real-world data analysisGeorge W Jr Sledge, Joanne Xiu, Jeffrey Peter Solzak, et al.
Pageof 11

Showing results (21-30 of 102) with videos related to

Sort By:
Pageof 11
Frontiers in Oncology|November 4, 2022
A phase II study of buparlisib in relapsed or refractory thymomasMohammad I Abu Zaid, Milan Radovich, Sandra Althouse, et al.
NPJ Breast Cancer|June 27, 2017
Dual PI3K and Wnt pathway inhibition is a synergistic combination against triple negative breast cancerJeffrey P Solzak, Rutuja V Atale, Bradley A Hancock, et al.
JCO Precision Oncology|February 14, 2023
Clinicogenomic Landscape of Metastatic Thymic Epithelial TumorsFatemeh Ardeshir-Larijani, Bryan P Schneider, Sandra K Althouse, et al.
Cancer Cell|October 17, 2025
TET2-mutant clonal hematopoiesis enhances macrophage antigen presentation and improves immune checkpoint therapy in solid tumorsShelley Herbrich, Mehdi Chaib, Swetha Anandhan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2018
Germline and Somatic DNA Damage Repair Gene Mutations and Overall Survival in Metastatic Pancreatic Adenocarcinoma Patients Treated with FOLFIRINOXAmikar Sehdev, Olumide Gbolahan, Brad A Hancock, et al.
JCO Precision Oncology|January 20, 2022
Implications of Incidental Germline Findings Identified In the Context of Clinical Whole Exome Sequencing for Guiding Cancer TherapyBryan P Schneider, Leigh Anne Stout, Santosh Philips, et al.
Plos Biology|September 30, 2017
Transcriptome analysis of hypoxic cancer cells uncovers intron retention in EIF2B5 as a mechanism to inhibit translationLauren K Brady, Hejia Wang, Caleb M Radens, et al.
JCO Precision Oncology|February 9, 2022
Homologous Recombination Deficiency in Patients With Pancreatic Ductal Adenocarcinoma and Response to ChemotherapySafi Shahda, Kirsten M Timms, Ashley A Ibrahim, et al.
Journal of Leukocyte Biology|February 8, 2006
DC-SIGN (CD209) recognition of Neisseria gonorrhoeae is circumvented by lipooligosaccharide variationPei Zhang, Olivier Schwartz, Milica Pantelic, et al.
Breast Cancer Research : BCR|August 12, 2025
Comparison of trastuzumab deruxtecan and sacituzumab govitecan in HER2-negative metastatic breast cancer: a large real-world data analysisGeorge W Jr Sledge, Joanne Xiu, Jeffrey Peter Solzak, et al.
Pageof 11